REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoeconomic analysis, which structure and interpretatio...

Full description

Bibliographic Details

Published in:	Фармакоэкономика
Main Authors:	Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-09-01
Subjects:	pharmacoeconomics orphan drugs rare diseases cost-utility analysis
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/98